Skip to main content
Premium Trial:

Request an Annual Quote

Oncocyte: Medical Advisory Board

Oncocyte said it has formed a new medical advisory board to advise the company on the development and clinical advancement of its portfolio of tests, including its immuno-oncology and blood-based monitoring tests.

Chairing the MAB is David Gandara, professor of medicine emeritus at the UC Davis School of Medicine. Gandara is a recognized authority in biomarker research and drug development in oncology, with extensive experience in translational research in lung cancer. Other board members include Daniel Hayes, professor at the University of Michigan Rogel Cancer Center; Fred Hirsch, executive director at the Center of Thoracic Oncology in the Tisch Cancer Institute at Mount Sinai and professor of medicine at the Icahn School of Medicine; Heinz-Josef Lenz, co-leader of the gastrointestinal cancers program at the USC Norris Comprehensive Cancer Center; and Ignacio Wistuba, chair of the department of translational molecular pathology at The University of Texas MD Anderson Cancer Center.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.